Alibhai Imran Nizamudin bought TVRD

December 16, 2025 · Form 4 insider transaction

Alibhai Imran Nizamudin bought 47,500 shares of Tvardi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
47,500
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after47,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.

View the original Form 4 on SEC EDGAR